SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Microcap & Penny Stocks : Microcap Potential Homeruns--Credible, and Reporting

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Ted M who wrote (687)1/11/2011 6:03:04 AM
From: thomas a. burke1 Recommendation  Read Replies (2) of 1056
 
ISCR...here are some of yesterdays projections boiled down. Of course I always like seeing these numbers in the rearview mirror as opposed to projections. In any case, based on what I have read over the last six months, these numbers should be very close, if not a bit light.

Revenue generated by Genstrip sales in 2011 = $48,200,000

Costs involved with Genstrip for 2011 = $35,400,000

Profit from Genstrip for 2011 = $12,800,000

Yielding income of 12.8 cents per share. Even though a growing medical supplies company would usually demand a much higher P/E, I will give us a p/e of 20 and that would yield a share price of $2.56. Remember, this is only for their Genstrip product. They still have an existing business that generates 20M in revenues and is very slightly profitable.

The guidance update on the 24th to be followed by a CC, will shed much more light on ISCR operations and I think that is when the fuse will be lit. Until then, I hope we see a measured and steady increase in volume and shareprice. I will hold this one for a long time as I think it is a rare company that has been kicked down to this level and is just coming off the mat.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext